colfosceril-palmitate and Neoplasms

colfosceril-palmitate has been researched along with Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for colfosceril-palmitate and Neoplasms

ArticleYear
Lipid-coated superparamagnetic nanoparticles for thermoresponsive cancer treatment.
    International journal of pharmaceutics, 2018, Sep-05, Volume: 548, Issue:1

    Poor aqueous solubility, chemical instability, and indiscriminate cytotoxicity have limited clinical development of camptothecin (CPT) as potent anticancer therapeutic. This research aimed at fabricating thermoresponsive nanocomposites that enhance solubility and stability of CPT in aqueous milieu and enable stimulus-induced drug release using magnetic hyperthermia. 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and l-α-dipalmitoylphosphatidyl glycerol (DPPG) (1:1, mol/mol) were immobilized on the surface of superparamagnetic Fe

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Cell Survival; Drug Liberation; Humans; Hyperthermia, Induced; Jurkat Cells; Magnetite Nanoparticles; Neoplasms; Phosphatidylglycerols

2018